Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
Single level serratus anterior plane block: Serratus anterior plane block with local anesthetics at the third rib
Single level serratus anterior plane block with dexmedetomidine: Serratus anterior plane block with local anesthetics and dexmedetomidine at the third rib
Bilevel serratus anterior plane block: Serratus anterior plane block with local anesthetics at the third and fifth rib
Bilevel serratus anterior plane block with dexmedetomidine: Serratus anterior plane block with local anesthetics and dexmedetomidine at the third and fifth rib
Study summary
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regarding pain control and possible side effects.
Eligibility
Primary outcome measure(s)
- First time to receive analgesia — First 24 hours postoperatively
first time to receive morphine analgesia in hours - Total analgesic requisite — First 24 hours postoperatively
total amount of morphine consumption in the first 24 hours postoperatively in mg
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Walaa Y Elsabeeny | Cairo | Cairo Governorate | Recruiting |
More National Cancer Institute, Egypt trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05361837 on ClinicalTrials.gov ↗ ← All trials in Egypt